Recent studies suggest that loss of cell cycle control by p53 and/or p16Ink4A loss of functions sensitize (pre)HNSCC cells to Wee1, Chk1 and PLK1 inhibition [84,109,110,111,112]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.